Association of anaemia and mortality in patients with acute pulmonary embolism

Thrombosis and Haemostasis

Volumn 102, Issue 1, 2009, Pages 153-158

  Jiménez Castro, David ^a   Escobar, Carlos ^a   Martí, David ^a   Díaz, Gema ^a   César, Jesús ^a   García Avello, Ángel ^a   Sueiro, Antonio ^a   Yusen, Roger D ^b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anaemia; Clinical studies; Lung; Prognosis; Pulmonary embolism

Indexed keywords

CREATININE; HEMOGLOBIN;

ADULT; AGED; ANEMIA; ARTICLE; BLEEDING; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FATALITY; FEMALE; FILTER; HEMODYNAMICS; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; INFERIOR CAVA VEIN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; SYMPTOMATOLOGY;

ACUTE DISEASE; ADULT; AGED; ANEMIA; COHORT STUDIES; FEMALE; HEMATOCRIT; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PULMONARY EMBOLISM; RISK FACTORS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 67749086362     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-01-0003     Document Type: Article

References (26)

1. Konstantinides S. Diagnosis and therapy of pulmonary embolism. VASA 2006; 35: 135-146.
2. Heit JA. Venous thromboembolism: disease burden, outcomes and risk factors. J Thromb Haemost 2005; 3: 1611-1617.
3. Bremberg ER, Brandberg Y, Hising C, et al. Anemia and quality of life including anemia-related symptoms in patients with solid tumors in clinical practice. Med Oncol 2007; 24: 95-102.
4. Bokemeyer C, Aapro MS, Courdi A, et al. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update. Eur J Cancer 2007; 43: 258-270.
5. Bohlius J, Weingart O, Trelle S, Engert A. Cancer-related anemia and recombinant human erythropoietin - an updated overview. Nat Clin Pract Oncol 2006; 3: 152-164.
6. Means RT. Pathogenesis of the anemia of chronic disease: a cytokine-mediated anemia. Stem Cells 1995; 13: 32-37.
7. Szachniewicz J, Petruk-Kowalczyk J, Majda J, et al. Anemia is an independent predictor of poor outcome in patients with chronic heart failure. Int J Cardiol 2003; 90: 303-308.
8. Redondo-Bermejo B, Pascual-Figal DA, Hurtado-Martínez JA, et al. Clinical determinants and prognostic value of hemoglobin in hospitalized patients with systolic heart failure. Rev Esp Cardiol 2007; 60: 597-606.
9. Horwich TB, Fonarow GC, Hamilton MA, et al. Anemia is associated with worse symptoms, greater impairment in functional capacity and significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002; 39: 1789-1786.
10. The PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism: results of the Prospective Investigation of Pulmonary Embolism Diagnosis. J Am Med Assoc 1990; 263: 2753-2769.
11. Remy-Jardin M, Remy J, Wattinne L, et al. Central pulmonary thromboembolism: diagnosis with spiral volumetric CT with the single-breathhold-technique-comparison with pulmonary angiography. Radiology 1992; 185: 381-387.
12. World Health Organization. Nutritional anaemias: report of a WHO scientific group. Geneva, Switzerland: World Health Organization, 1968.
13. Al-Ahmad A, Rand SM, Manjunath G, et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 2001; 38: 955-962.
14. O'Meara E, Clayton T, McEntegart MB, et al. Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: assessment of reduction in mortality and morbidity (CHARM) program. Circulation 2006; 113: 986-994.
15. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes. Circulation 2003; 107: 223-225.
16. Anand IS, Chandrasehekhar Y, Ferrari R, et al. Pathogenesis of oedema in chronic severe anemia: studies of body water and sodium, renal function, haemodinamic variables, and plasma hormones. Br Heart J 1993; 70: 357-362.
17. Weiskopf RB, Viele MK, Feiner J, et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. J Am Med Assoc 1998; 279: 217-221.
18. Conget F, Otero R, Jiménez D, et al. Short-term clinical outcome after acute symptomatic pulmonary embolism. Thromb Haemost 2008; 100: 937-942.
19. Ruiz-Giménez N, Suárez C, González R, et al., and the RIETE investigators. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE registry. Thromb Haemost 2008; 100: 26-31.
20. Bentel G, Ganser A. Risks and benefits of erythropoiesis-stimulating agents in cancer management. Semin Hematol 2007; 44: 157-165.
21. Hurter B, Bush NJ. Cancer-related anemia: clinical review and management update. Clin J Oncol Nurse 2007; 11: 349-359.
22. Schwartz RN. Anemia in patients with cancer: incidence, causes, impact, management, and use of treatment guidelines and protocols. Am J Health Syst Pharm 2007; 64: 5-13.
23. Monreal M, Falga C, Valle R, et al. Venous thromboembolism in patients with renal insufficiency: findings from the RIETE registry. Am J Med 2006; 119: 1073-1079.
24. Trujillo-Santos J, Herrera S, Page MA, et al. Predicting adverse outcome in outpatients with acute deep vein thrombosis: findings from the RIETE registry. J Vasc Surg 2006; 44: 789-793.
25. Jiménez D, Díaz G, Molina J, et al. Troponin I and risk stratification of patients with acute non massive pulmonary embolism. Eur Respir J 2008; 31: 847-853.
26. Sanchez O, Trinquart L, Colombet I, et al. Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review. Eur Heart J 2008; 29: 1569-1577.